Survival prediction and response to immune checkpoint inhibitors: A prognostic immune signature for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the most common cancers all over the world. Several studies have explored if immune-related genes and tumor immune microenvironment could play roles in HCC prognoses. This study is aimed at developing a prognostic signature of HCC based on immune-related gene...
Main Authors: | Ying Xu, Zheng Wang, Fufeng Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | Translational Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523320304496 |
Similar Items
-
The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment
by: Patrizia Leone, et al.
Published: (2021-05-01) -
Identification of a prognostic immune signature for cervical cancer to predict survival and response to immune checkpoint inhibitors
by: Si Yang, et al.
Published: (2019-12-01) -
Immune checkpoint inhibitors in the treatment of hepatocellular carcinoma
by: Zeynep Akbulut, et al.
Published: (2024-04-01) -
Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma
by: Yanan Peng, et al.
Published: (2021-02-01) -
Emerging Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
by: Vito Longo, et al.
Published: (2019-10-01)